West Pharmaceutical Services has underperformed other medical devices stocks over the past year, yet analysts remain bullish on the stock’s prospects.
West Pharmaceutical Services has substantially underperformed the broader market year over the past year, yet analysts remain bullish on the stock’s prospects.
The S&P 500 Index ($SPX ) (SPY ) Thursday closed up by +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.33%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.83%. Stocks...
The S&P 500 Index ($SPX ) (SPY ) today is up by +0.20%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.63%. Stocks today are mostly...
The S&P 500 Index ($SPX ) (SPY ) today is up by +0.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.65%. Stocks today are mostly...
West Pharmaceutical: Q3 Earnings Snapshot
West Pharmaceutical is scheduled to report its third-quarter results later this month, and analysts expect a double-digit earnings decline.
Despite West Pharmaceutical underperforming the healthcare sector, Wall Street analysts remain highly optimistic about the stock’s prospects.
West Pharmaceutical Services has underperformed the broader market over the past year, but Wall Street analysts remain optimistic about the stock’s prospects.
West Pharmaceutical: Q2 Earnings Snapshot